Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of Dexmedetomidine as Myocardial Protector in Pediatric Cardiac Surgery Total Correction of Tetralogy of Fallot

NCT05579964 is registered in ClinicalTrials.gov with National Cardiovascular Center Harapan Kita Hospital Indonesia as lead sponsor.

NCT NCT05579964
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05579964 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of Dexmedetomidine as Myocardial Protector in Pediatric Cardiac Surgery Total Correction of Tetralogy of Fallot
Lead sponsor
National Cardiovascular Center Harapan Kita Hospital Indonesia
Phase
Phase 2/3
Overall status
Completed
Start date
October 10, 2022
Completion date
June 10, 2023
Enrollment
66 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiopulmonary bypass, congenital heart disease in children, tetralogy of fallot